Author
Listed:
- Joy L. Nishikawa
(Massachusetts General Hospital Cancer Center
Harvard Medical School)
- Andras Boeszoermenyi
(Harvard Medical School)
- Luis A. Vale-Silva
(Institute of Microbiology, University Hospital Lausanne and University Hospital Center)
- Riccardo Torelli
(Institute of Microbiology, Università Cattolica del Sacro Cuore)
- Brunella Posteraro
(Institute of Public Health, Università Cattolica del Sacro Cuore)
- Yoo-Jin Sohn
(Massachusetts General Hospital Cancer Center
Harvard Medical School)
- Fei Ji
(Massachusetts General Hospital, Boston
Harvard Medical School)
- Vladimir Gelev
(Faculty of Chemistry and Pharmacy, Sofia University)
- Dominique Sanglard
(Institute of Microbiology, University Hospital Lausanne and University Hospital Center)
- Maurizio Sanguinetti
(Institute of Microbiology, Università Cattolica del Sacro Cuore)
- Ruslan I. Sadreyev
(Massachusetts General Hospital, Boston
Massachusetts General Hospital and Harvard Medical School)
- Goutam Mukherjee
(Indian Institute of Technology Delhi
Supercomputing Facility for Bioinformatics & Computational Biology, Indian Institute of Technology Delhi)
- Jayaram Bhyravabhotla
(Indian Institute of Technology Delhi
Supercomputing Facility for Bioinformatics & Computational Biology, Indian Institute of Technology Delhi
Kusuma School of Biological Sciences, Indian Institute of Technology Delhi)
- Sara J. Buhrlage
(Harvard Medical School
Dana-Farber Cancer Institute)
- Nathanael S. Gray
(Harvard Medical School
Dana-Farber Cancer Institute)
- Gerhard Wagner
(Harvard Medical School)
- Anders M. Näär
(Massachusetts General Hospital Cancer Center
Harvard Medical School)
- Haribabu Arthanari
(Harvard Medical School)
Abstract
A small molecule, inhibitor of a protein–protein interaction between the transcription factor Pdr1 and the Med15 subunit of Mediator in the fungal pathogen Candida glabrata, is identified and characterized here; the compound iKIX1 inhibits Pdr1-mediated gene activation and resensitizes drug-resistant C. glabrata to azole antifungals in vitro and in animal models of disseminated and urinary tract infection.
Suggested Citation
Joy L. Nishikawa & Andras Boeszoermenyi & Luis A. Vale-Silva & Riccardo Torelli & Brunella Posteraro & Yoo-Jin Sohn & Fei Ji & Vladimir Gelev & Dominique Sanglard & Maurizio Sanguinetti & Ruslan I. Sa, 2016.
"Inhibiting fungal multidrug resistance by disrupting an activator–Mediator interaction,"
Nature, Nature, vol. 530(7591), pages 485-489, February.
Handle:
RePEc:nat:nature:v:530:y:2016:i:7591:d:10.1038_nature16963
DOI: 10.1038/nature16963
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:530:y:2016:i:7591:d:10.1038_nature16963. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.